Magdalena O. Cilella, Ph.D.

Magdalena Cilella's intellectual law practice focuses on patent prosecution with an emphasis on molecular/cell biology, pharmaceuticals and biotechnology.

Dr. Cilella brings to the firm a strong research background including experiences in neurodegeneration and tauopathies, specializing in intransglutaminase-induced cross-linking in progressive supranuclear palsy and the effects of Echinacea (over-the-counter dietary supplement) on the human immune system.

• Student Speaker Representative, Chicago Chapter for Neuroscience Annual Scientific Meeting, Loyola University Chicago, 2001
• Arthur J. Schmitt Dissertation Fellowship for outstanding academic achievements and in recognition of the scholarly promise of the proposed dissertation research, 2000
• Great Lakes Chapter/American Society for Pharmacology and Experimental Therapeutics, 3rd place award (poster presentation), 2000.

• "Transglutaminase Enzyme Activity and Expression of Transglutaminase 1 are increased in Progressive Supranuclear Palsy," co-author, J Neuropath Exp Neurol,"62(2), February 2003, pgs 173-84
• "Transglutaminase-Induced Cross-Linking of Tau Proteins in Progressive Supranuclear Palsy," co-author, J Neuropath Exp Neurol. 59(11), November 2000, pgs 983-9

• "Involvement of Transglutaminase Enzyme in Progressive Supranuclear Palsy," co-presenter, Society for Neuroscience Chicago Chapter, Chicago, Illinois

• Society for Neuroscience
• American Society for Pharmacology and Experimental Therapeutics
• American Association for the Advancement of Science
• Intellectual Property Owners Association

• Brinks Hofer Gilson & Lione Announces New Hires and Promotions for Year

• Leading Lawyers Network